-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Regeneron Pharmaceuticals, Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from Q3 2021 to Q4 2022.
- Regeneron Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending December 31, 2022 was $37.6M.
- Regeneron Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $92.2M, a 145% increase from 2022.
- Regeneron Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $37.6M.